Piomic

Concurrent optical and magnetic stimulation (COMS) for treatment of refractory diabetic foot ulcer; a prospective randomized, sham-controlled, double-blinded, pivotal clinical trial.

Criteria:

• Type 1 or 2 diabetic
• Chronic non-healing wound on the foot
• Wound not infected or ischemic
• Willing to attend 2x week visits for 24 weeks total, 8 weeks of TX